Cancer Heterogeneity and Plasticity ISSN 2818-7792

Cancer Heterogeneity and Plasticity 2025;2(4):0018 | https://doi.org/10.47248/chp2502040018

Conference Report Open Access

Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in Cancer

Hans Clevers 1 , Ankur Sharma 2 , Sendurai A. Mani 3,4 , Anna Golebiewska 5 , Axel Behrens 6,7,8 , Wai Leong Tam 9,10 , Loic P. Deleyrolle 11 , Huiping Liu 12 , Karuna Ganesh 13,14 , Walid T. Khaled 15,16 , Shaheen Sikandar 17 , Terence K. Lee 18 , Tyler E. Miller 19 , Dean G. Tang 20 , Sheila Singh 21,22,23 , Vivian S.W. Li 24 , Justin D. Lathia 25,26,27,28 , Stephanie Ma 29,30

  • Pharma, Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland
  • Translational Genomics Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
  • Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI 02912, USA
  • Legorreta Cancer Center, The Warren Alpert Medical School, Brown University, Providence, RI 02912, USA
  • NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, L-1210 Luxembourg, Luxembourg
  • Cancer Stem Cell Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
  • Department of Surgery and Cancer, Imperial College London, London, UK
  • Convergence Science Centre, Imperial College London, London, UK
  • Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis Street, Genome, Singapore, 138672, Singapore
  • Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore
  • Department of Molecular Medicine, Mayo Clinic, Jacksonville, FL, 32224, USA
  • Circulating Tumor Cell Core, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA
  • Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Department of Pharmacology, University of Cambridge, Cambridge, UK
  • Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
  • Department of Molecular, Cell and Developmental Biology, University of California - Santa Cruz, Santa Cruz, CA, 95064, USA
  • Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong SAR, China
  • Department of Pathology, Case Western Reserve University School of Medicine and Case Comprehensive Cancer Center, Cleveland, OH, 44106-7285, USA
  • Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA
  • Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada
  • Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON L8S 4L8, Canada
  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada
  • Stem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK
  • Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH 44106, USA
  • Case Comprehensive Cancer Center, Cleveland, OH 44106, USA
  • Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH 44195, USA
  • School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
  • State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China

Correspondence: Vivian S.W. Li; Justin D. Lathia; Stephanie Ma

Received: Oct 3, 2025 | Accepted: Oct 3, 2025 | Published: Oct 17, 2025

Cite this article: Clevers H, Sharma A, Mani SA, Golebiewska A, Behrens A, Tam WL, Deleyrolle LP, Liu H, Ganesh K, Khaled WT, Sikandar S, Lee TK, Miller TE, Tang DG, Singh S, Li VS, Lathia JD, Ma S. Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in Cancer. Cancer Heterog Plast. 2025;2(4):0018. https://doi.org/10.47248/chp2502040018

Abstract

The inaugural FASEB Science Research Conference (SRC) on Cellular Plasticity in Cancer was held in May 2025 in Hong Kong SAR, China. This event brought together leading experts to discuss cutting-edge research centered on cancer cell plasticity. The conference featured comprehensive presentations covering a broad spectrum of topics, including oncofetal reprogramming in tumor development and progression, mechanisms regulating cancer cell plasticity, metabolic reprogramming and its role in tumor progression, cancer cell plasticity during metastasis, cancer stem cell programs within the tumor microenvironment, tumor plasticity and immune evasion, as well as innovative therapeutic strategies aimed at targeting stem cell-like states, modulating cancer cell states, and effectively controlling disease progression. It is anticipated that the insights gained from this meeting will catalyze further advancements in cancer biology and therapy.

Keywords

cancer cell plasticity, cellular plasticity, cancer stem cells, phenotypic switching, therapy resistance, tumor microenvironment, immune evasion

Share this article

About Us Journals Join Us Submit Fees Contact